DocSym
β
Searchsearch
Search
(M80.0) Postmenopausal osteoporosis with pathological fracture
More details coming soon
1 643 865 in individuals diagnosis postmenopausal osteoporosis with pathological fracture confirmed
39 170 deaths with diagnosis postmenopausal osteoporosis with pathological fracture
2% mortality rate associated with the disease postmenopausal osteoporosis with pathological fracture
Diagnosis postmenopausal osteoporosis with pathological fracture is diagnosed Women are 68.17% more likely than Men
261 629
Men receive the diagnosis postmenopausal osteoporosis with pathological fracture
13 318 (5.1 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
1 382 236
Women receive the diagnosis postmenopausal osteoporosis with pathological fracture
25 852 (1.9 %)Died from this diagnosis.
Risk Group for the Disease postmenopausal osteoporosis with pathological fracture - Men and Women aged 80-84
In Men diagnosis is most often set at age 0-19, 25-95+
Less common in men the disease occurs at Age 20-24in in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features postmenopausal osteoporosis with pathological fracture
Absence or low individual and public risk
Postmenopausal osteoporosis with pathological fracture - what does this mean
Postmenopausal osteoporosis with pathological fracture is a condition in which a fracture occurs in a weakened bone due to the gradual loss of bone density that occurs after menopause. this is caused by a decline in the female sex hormones, estrogen, which leads to an increased risk of bone loss and fragility.
What happens during the disease - postmenopausal osteoporosis with pathological fracture
Postmenopausal osteoporosis is a condition in which bone density decreases due to a decrease in estrogen production after menopause. this decrease in bone density can increase the risk of bone fractures, known as pathological fractures. these fractures occur because the bones become weak and brittle, and are more prone to fracture when exposed to minor trauma or even everyday activities.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Clinical history and physical examination
- Radiological examination (X-ray, CT scan, MRI scan)
- Bone Mineral Density (BMD) test
- Blood tests (for calcium, phosphate, alkaline phosphatase, vitamin D, parathyroid hormone, etc.)
- Urinary tests (for calcium, creatinine, etc.)
- Biochemical markers (for bone resorption and formation)
- Bone biopsy (to measure bone turnover)
Treatment and Medical Assistance
Main goal of the treatment: To reduce pain, improve mobility, and reduce the risk of further fractures.
- Prescription of bisphosphonates to reduce bone resorption and increase bone density
- Supplementation with vitamin D and calcium to improve bone health
- Physical therapy to improve mobility and reduce pain
- Weight-bearing exercises to improve bone density and reduce the risk of fractures
- Medications to reduce pain and inflammation
- Surgery to repair the fracture
23 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Postmenopausal osteoporosis with pathological fracture - Prevention
The best way to prevent postmenopausal osteoporosis with pathological fracture is to ensure that women receive adequate calcium and vitamin d throughout their lives, engage in weight-bearing exercise, and avoid smoking and excessive alcohol consumption. additionally, women should have regular bone density screenings to detect and monitor any changes in bone density.